Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective

Pediatric Differentiated Thyroid Cancer (pedDTC) is a rare pediatric malignancy with an increasing incidence over time. To date, there is a paucity of literature specifically addressing pedDTC within the context of Middle Eastern ethnicity. This retrospective study aimed to assess the risk-stratifyi...

Full description

Bibliographic Details
Main Authors: Akram Al-Ibraheem, Mohamed Al-Shammaa, Ahmed Saad Abdlkadir, Feras Istatieh, Ula Al-Rasheed, Thomas Pascual, Rawad Rihani, Hadeel Halalsheh, Taleb Ismael, Aysar Khalaf, Iyad Sultan, Issa Mohamad, Hikmat Abdel-Razeq, Asem Mansour
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/14/1/158
_version_ 1797343128847384576
author Akram Al-Ibraheem
Mohamed Al-Shammaa
Ahmed Saad Abdlkadir
Feras Istatieh
Ula Al-Rasheed
Thomas Pascual
Rawad Rihani
Hadeel Halalsheh
Taleb Ismael
Aysar Khalaf
Iyad Sultan
Issa Mohamad
Hikmat Abdel-Razeq
Asem Mansour
author_facet Akram Al-Ibraheem
Mohamed Al-Shammaa
Ahmed Saad Abdlkadir
Feras Istatieh
Ula Al-Rasheed
Thomas Pascual
Rawad Rihani
Hadeel Halalsheh
Taleb Ismael
Aysar Khalaf
Iyad Sultan
Issa Mohamad
Hikmat Abdel-Razeq
Asem Mansour
author_sort Akram Al-Ibraheem
collection DOAJ
description Pediatric Differentiated Thyroid Cancer (pedDTC) is a rare pediatric malignancy with an increasing incidence over time. To date, there is a paucity of literature specifically addressing pedDTC within the context of Middle Eastern ethnicity. This retrospective study aimed to assess the risk-stratifying factors for overall survival (OS) and event-free survival (EFS) in pediatric DTC patients from Iraq and Jordan. The medical records of 81 patients from two tertiary cancer institutes were retrieved. Kaplan–Meier analysis was employed to investigate OS and EFS, and the Cox proportional hazards model was employed to estimate hazard ratios. All patients underwent surgery and radioactive iodine therapy, with a median age of 14 and an interquartile range of 12–15. Lymph node involvement was observed in 55% of cases, while distant metastases were present in 13.5%. After a median follow-up period of 68 months, the 10-year survival rate was determined to be 94%, while the 10-year EFS rate was 58%. EFS was negatively impacted by cervical lymph node metastases and early age of diagnosis (<i>p</i> ≤ 0.01, each). Therefore, pediatrics with initial cervical lymph node metastases and those diagnosed before puberty tend to experience poorer EFS, which may justify the need for more aggressive management plans.
first_indexed 2024-03-08T10:43:11Z
format Article
id doaj.art-53d8e8307a024da4bfecb7624310186b
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-08T10:43:11Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-53d8e8307a024da4bfecb7624310186b2024-01-26T17:21:54ZengMDPI AGLife2075-17292024-01-0114115810.3390/life14010158Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern PerspectiveAkram Al-Ibraheem0Mohamed Al-Shammaa1Ahmed Saad Abdlkadir2Feras Istatieh3Ula Al-Rasheed4Thomas Pascual5Rawad Rihani6Hadeel Halalsheh7Taleb Ismael8Aysar Khalaf9Iyad Sultan10Issa Mohamad11Hikmat Abdel-Razeq12Asem Mansour13Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Nuclear Medicine, Radiotherapy and Nuclear Medicine Hospital, Bab Al-Muadham, Baghdad 10047, IraqDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanPhilippine Nuclear Research Institute, Department of Science and Technology, Quezon City 1101, PhilippinesDepartment of Pediatrics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Pediatrics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Pediatrics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Nuclear Medicine, Warith International Cancer Institute, Karbala 56001, IraqDepartment of Pediatrics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Radiation Oncology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanDepartment of Diagnostic Radiology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, JordanPediatric Differentiated Thyroid Cancer (pedDTC) is a rare pediatric malignancy with an increasing incidence over time. To date, there is a paucity of literature specifically addressing pedDTC within the context of Middle Eastern ethnicity. This retrospective study aimed to assess the risk-stratifying factors for overall survival (OS) and event-free survival (EFS) in pediatric DTC patients from Iraq and Jordan. The medical records of 81 patients from two tertiary cancer institutes were retrieved. Kaplan–Meier analysis was employed to investigate OS and EFS, and the Cox proportional hazards model was employed to estimate hazard ratios. All patients underwent surgery and radioactive iodine therapy, with a median age of 14 and an interquartile range of 12–15. Lymph node involvement was observed in 55% of cases, while distant metastases were present in 13.5%. After a median follow-up period of 68 months, the 10-year survival rate was determined to be 94%, while the 10-year EFS rate was 58%. EFS was negatively impacted by cervical lymph node metastases and early age of diagnosis (<i>p</i> ≤ 0.01, each). Therefore, pediatrics with initial cervical lymph node metastases and those diagnosed before puberty tend to experience poorer EFS, which may justify the need for more aggressive management plans.https://www.mdpi.com/2075-1729/14/1/158pediatric thyroid cancerMiddle Easternevent-free survivalchildrendistant metastasislymph node metastasis
spellingShingle Akram Al-Ibraheem
Mohamed Al-Shammaa
Ahmed Saad Abdlkadir
Feras Istatieh
Ula Al-Rasheed
Thomas Pascual
Rawad Rihani
Hadeel Halalsheh
Taleb Ismael
Aysar Khalaf
Iyad Sultan
Issa Mohamad
Hikmat Abdel-Razeq
Asem Mansour
Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
Life
pediatric thyroid cancer
Middle Eastern
event-free survival
children
distant metastasis
lymph node metastasis
title Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
title_full Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
title_fullStr Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
title_full_unstemmed Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
title_short Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective
title_sort survival trends in pediatric differentiated thyroid cancer a middle eastern perspective
topic pediatric thyroid cancer
Middle Eastern
event-free survival
children
distant metastasis
lymph node metastasis
url https://www.mdpi.com/2075-1729/14/1/158
work_keys_str_mv AT akramalibraheem survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT mohamedalshammaa survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT ahmedsaadabdlkadir survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT ferasistatieh survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT ulaalrasheed survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT thomaspascual survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT rawadrihani survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT hadeelhalalsheh survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT talebismael survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT aysarkhalaf survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT iyadsultan survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT issamohamad survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT hikmatabdelrazeq survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective
AT asemmansour survivaltrendsinpediatricdifferentiatedthyroidcanceramiddleeasternperspective